[HTML][HTML] Patient-Derived Multiple Myeloma 3D Models for Personalized Medicine—Are We There Yet?
D Lourenço, R Lopes, C Pestana, AC Queirós… - International Journal of …, 2022 - mdpi.com
Despite the wide variety of existing therapies, multiple myeloma (MM) remains a disease
with dismal prognosis. Choosing the right treatment for each patient remains one of the …
with dismal prognosis. Choosing the right treatment for each patient remains one of the …
Patient-Derived Multiple Myeloma 3D Models for Personalized Medicine-Are We There Yet?
D Lourenço, R Lopes, C Pestana… - International …, 2022 - pubmed.ncbi.nlm.nih.gov
Despite the wide variety of existing therapies, multiple myeloma (MM) remains a disease
with dismal prognosis. Choosing the right treatment for each patient remains one of the …
with dismal prognosis. Choosing the right treatment for each patient remains one of the …
[PDF][PDF] Patient-Derived Multiple Myeloma 3D Models for Personalized Medicine—Are We There Yet
D Lourenço, R Lopes, C Pestana, AC Queirós… - Int. J. Mol …, 2022 - novaresearch.unl.pt
Despite the wide variety of existing therapies, multiple myeloma (MM) remains a disease
with dismal prognosis. Choosing the right treatment for each patient remains one of the …
with dismal prognosis. Choosing the right treatment for each patient remains one of the …
Patient-Derived Multiple Myeloma 3D Models for Personalized Medicine—Are We There Yet?
D Lourenço, R Lopes, C Pestana, AC Queirós, C João… - 2022 - agris.fao.org
Despite the wide variety of existing therapies, multiple myeloma (MM) remains a disease
with dismal prognosis. Choosing the right treatment for each patient remains one of the …
with dismal prognosis. Choosing the right treatment for each patient remains one of the …
[PDF][PDF] Patient-Derived Multiple Myeloma 3D Models for Personalized Medicine—Are We There Yet
D Lourenço, R Lopes, C Pestana… - Int. J. Mol …, 2022 - pdfs.semanticscholar.org
Despite the wide variety of existing therapies, multiple myeloma (MM) remains a disease
with dismal prognosis. Choosing the right treatment for each patient remains one of the …
with dismal prognosis. Choosing the right treatment for each patient remains one of the …
Patient-Derived Multiple Myeloma 3D Models for Personalized Medicine—Are We There Yet?
D Lourenço, R Lopes, C Pestana… - International …, 2022 - search.ebscohost.com
Despite the wide variety of existing therapies, multiple myeloma (MM) remains a disease
with dismal prognosis. Choosing the right treatment for each patient remains one of the …
with dismal prognosis. Choosing the right treatment for each patient remains one of the …
[PDF][PDF] Patient-Derived Multiple Myeloma 3D Models for Personalized Medicine—Are We There Yet
D Lourenço, R Lopes, C Pestana, AC Queirós, C João… - Int. J. Mol. Sci, 2022 - run.unl.pt
Despite the wide variety of existing therapies, multiple myeloma (MM) remains a disease
with dismal prognosis. Choosing the right treatment for each patient remains one of the …
with dismal prognosis. Choosing the right treatment for each patient remains one of the …
Patient-Derived Multiple Myeloma 3D Models for Personalized Medicine-Are We There Yet?
D Lourenço, R Lopes, C Pestana… - … Journal of Molecular …, 2022 - europepmc.org
Despite the wide variety of existing therapies, multiple myeloma (MM) remains a disease
with dismal prognosis. Choosing the right treatment for each patient remains one of the …
with dismal prognosis. Choosing the right treatment for each patient remains one of the …
[PDF][PDF] Patient-Derived Multiple Myeloma 3D Models for Personalized Medicine—Are We There Yet
D Lourenço, R Lopes, C Pestana, AC Queirós… - Int. J. Mol. Sci, 2022 - research.unl.pt
Despite the wide variety of existing therapies, multiple myeloma (MM) remains a disease
with dismal prognosis. Choosing the right treatment for each patient remains one of the …
with dismal prognosis. Choosing the right treatment for each patient remains one of the …
Patient-Derived Multiple Myeloma 3D Models for Personalized Medicine—Are We There Yet?
D Lourenço, R Lopes, C Pestana… - International …, 2022 - search.proquest.com
Despite the wide variety of existing therapies, multiple myeloma (MM) remains a disease
with dismal prognosis. Choosing the right treatment for each patient remains one of the …
with dismal prognosis. Choosing the right treatment for each patient remains one of the …